These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6235163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intradermal hepatitis B vaccination for mentally retarded patients.
    Hayashi J, Kashiwagi S, Noguchi A, Nakashima K, Ikematsu H, Kajiyama W.
    J Infect; 1989 Sep; 19(2):119-25. PubMed ID: 2530288
    [Abstract] [Full Text] [Related]

  • 4. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J, Noguchi A, Nakashima K, Morofuji M, Kashiwagi S.
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P, Vranckx R, Meheus A.
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J, Kashiwagi S, Noguchi A, Nakashima K, Ikematsu H, Kajiyama W, Nomura H.
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [Abstract] [Full Text] [Related]

  • 7. Epidemiology of hepatitis B e antigen and antibody in mentally retarded HBsAg carriers.
    Lohiya G, Lohiya S, Ngo VT, Crinella R.
    Hepatology; 1986 Sep; 6(2):163-6. PubMed ID: 2937706
    [Abstract] [Full Text] [Related]

  • 8. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID, Dimitrakakis M, Sharma DL.
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK, Perry E, Cleary TE.
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F, Andrle M, Horak W, Rett A.
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.
    Troisi CL, Heiberg DA, Hollinger FB.
    JAMA; 1985 Dec 13; 254(22):3196-9. PubMed ID: 2933533
    [Abstract] [Full Text] [Related]

  • 14. Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients.
    Torre D, Broggini M, Botta V, Sampietro C.
    Vaccine; 1989 Apr 13; 7(2):102-3. PubMed ID: 2526418
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ, de Witte-van der Schoot E, van Loon AM, Rijntjes PJ, Yap SH.
    Am J Epidemiol; 1988 Sep 13; 128(3):629-38. PubMed ID: 2970793
    [Abstract] [Full Text] [Related]

  • 16. Vaccination against hepatitis B in preschool children with Down's syndrome.
    Vajro P, Lettera P, Fontanella A, Sbreglia C, Manzillo E, Sartorio R, Del Giudice E.
    J Intellect Disabil Res; 1992 Feb 13; 36 ( Pt 1)():77-81. PubMed ID: 1533557
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine.
    Mölsä PK.
    J Ment Defic Res; 1990 Aug 13; 34 ( Pt 4)():379-83. PubMed ID: 2144593
    [Abstract] [Full Text] [Related]

  • 19. Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients.
    Cooper BW, Klimek JJ, Upadhyaya A, Devine S.
    Am J Infect Control; 1986 Oct 13; 14(5):204-8. PubMed ID: 3641542
    [Abstract] [Full Text] [Related]

  • 20. Modelling long-term persistence of hepatitis B antibodies after vaccination.
    Vellinga A, Van Damme P, Bruckers L, Weyler JJ, Molenberghs G, Meheus A.
    J Med Virol; 1999 Feb 13; 57(2):100-3. PubMed ID: 9892391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.